• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析 Schlafen 11、程序性死亡配体 1 和结直肠癌患者氧化还原状态的预后潜力。

Analysis of the Prognostic Potential of Schlafen 11, Programmed Death Ligand 1, and Redox Status in Colorectal Cancer Patients.

机构信息

Clinic for Digestive Surgery-First Surgical Clinic, University Clinical Center of Serbia, 11000 Belgrade, Serbia.

Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.

出版信息

Int J Mol Sci. 2023 Oct 11;24(20):15083. doi: 10.3390/ijms242015083.

DOI:10.3390/ijms242015083
PMID:37894765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10606719/
Abstract

The Schlafen 11 (SLFN11) protein has recently emerged as pivotal in DNA damage conditions, with predictive potential for tumor response to cytotoxic chemotherapies. Recent discoveries also showed that the programmed death ligand 1 (PD-L1) protein can be found on malignant cells, providing an immune evasion mechanism exploited by different tumors. Additionally, excessive generation of free radicals, redox imbalance, and consequential DNA damage can affect intestinal cell homeostasis and lead to neoplastic transformation. Therefore, our study aimed to investigate the significance of SLFN11 and PD-L1 proteins and redox status parameters as prognostic biomarkers in CRC patients. This study included a total of 155 CRC patients. SLFN11 and PD-L1 serum levels were measured with ELISA and evaluated based on redox status parameters, sociodemographic and clinical characteristics, and survival. The following redox status parameters were investigated: spectrophotometrically measured superoxide dismutase (SOD), sulfhydryl (SH) groups, advanced oxidation protein products (AOPP), malondialdehyde (MDA), pro-oxidant-antioxidant balance (PAB), and superoxide anion (O). The prooxidative score, antioxidative score, and OXY-SCORE were also calculated. The results showed significantly shorter survival in patients with higher OXY-SCOREs and higher levels of serum SLFN11, while only histopathology-analysis-related factors showed significant prognostic value. OXY-SCORE and SLFN11 levels may harbor prognostic potential in CRC patients.

摘要

SLFN11 蛋白在 DNA 损伤条件下最近被认为是至关重要的,对肿瘤对细胞毒化疗的反应具有预测潜力。最近的发现还表明,程序性死亡配体 1(PD-L1)蛋白可以在恶性细胞上找到,为不同的肿瘤提供了一种免疫逃避机制。此外,自由基的过度产生、氧化还原失衡以及随之而来的 DNA 损伤会影响肠道细胞的动态平衡,并导致肿瘤转化。因此,我们的研究旨在探讨 SLFN11 和 PD-L1 蛋白以及氧化还原状态参数作为 CRC 患者预后生物标志物的意义。这项研究共纳入了 155 名 CRC 患者。我们使用 ELISA 法测量了 SLFN11 和 PD-L1 的血清水平,并根据氧化还原状态参数、社会人口学和临床特征以及生存情况进行了评估。我们研究了以下氧化还原状态参数:分光光度法测量的超氧化物歧化酶(SOD)、巯基(SH)基团、高级氧化蛋白产物(AOPP)、丙二醛(MDA)、促氧化剂-抗氧化剂平衡(PAB)和超氧阴离子(O)。还计算了促氧化剂评分、抗氧化剂评分和 OXY-SCORE。结果显示,OXY-SCORE 较高和血清 SLFN11 水平较高的患者生存时间明显缩短,而只有组织病理学分析相关因素显示出显著的预后价值。OXY-SCORE 和 SLFN11 水平可能具有 CRC 患者的预后潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3476/10606719/04f6ff60f090/ijms-24-15083-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3476/10606719/04b30adb71fa/ijms-24-15083-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3476/10606719/b3cc7fbd9409/ijms-24-15083-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3476/10606719/886e462d7042/ijms-24-15083-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3476/10606719/04f6ff60f090/ijms-24-15083-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3476/10606719/04b30adb71fa/ijms-24-15083-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3476/10606719/b3cc7fbd9409/ijms-24-15083-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3476/10606719/886e462d7042/ijms-24-15083-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3476/10606719/04f6ff60f090/ijms-24-15083-g004.jpg

相似文献

1
Analysis of the Prognostic Potential of Schlafen 11, Programmed Death Ligand 1, and Redox Status in Colorectal Cancer Patients.分析 Schlafen 11、程序性死亡配体 1 和结直肠癌患者氧化还原状态的预后潜力。
Int J Mol Sci. 2023 Oct 11;24(20):15083. doi: 10.3390/ijms242015083.
2
Antioxidant Barrier, Redox Status, and Oxidative Damage to Biomolecules in Patients with Colorectal Cancer. Can Malondialdehyde and Catalase Be Markers of Colorectal Cancer Advancement?抗氧化屏障、氧化还原状态和生物分子氧化损伤与结直肠癌患者。丙二醛和过氧化氢酶可否作为结直肠癌进展的标志物?
Biomolecules. 2019 Oct 22;9(10):637. doi: 10.3390/biom9100637.
3
CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer.CMTM6 与 PD-L1 的共表达与结直肠癌中活跃的免疫微环境和良好的预后相关。
J Immunother Cancer. 2021 Feb;9(2). doi: 10.1136/jitc-2020-001638.
4
Impact of sidedness of colorectal cancer on tumor immunity.结直肠癌侧别对肿瘤免疫的影响。
PLoS One. 2020 Oct 12;15(10):e0240408. doi: 10.1371/journal.pone.0240408. eCollection 2020.
5
The clinicopathological and prognostic value of programmed death-ligand 1 in colorectal cancer: a meta-analysis.程序性死亡配体 1 在结直肠癌中的临床病理和预后价值:荟萃分析。
Clin Transl Oncol. 2019 May;21(5):674-686. doi: 10.1007/s12094-018-1970-9. Epub 2018 Nov 3.
6
Individual and Combined Effects of CTLA4-CD28 Variants and Oxidant-Antioxidant Status on the Development of Colorectal Cancer.CTLA4 - CD28基因变体与氧化还原状态对结直肠癌发生发展的个体及联合作用
Anticancer Res. 2015 Oct;35(10):5391-400.
7
Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.程序性细胞死亡蛋白1(PD-1)和PD-配体1(PD-L1)在大肠癌细胞及肿瘤浸润淋巴细胞中的表达对结直肠癌的预后影响
Mol Cancer. 2016 Aug 24;15(1):55. doi: 10.1186/s12943-016-0539-x.
8
Schlafen-11 sensitizes colorectal carcinoma cells to irinotecan.睡眠相关蛋白11使结肠癌细胞对伊立替康敏感。
Anticancer Drugs. 2014 Nov;25(10):1175-81. doi: 10.1097/CAD.0000000000000151.
9
B7-H3 and PD-L1 Expression Are Prognostic Biomarkers in a Multi-racial Cohort of Patients with Colorectal Cancer.B7-H3和PD-L1表达是多种族结直肠癌患者队列中的预后生物标志物。
Clin Colorectal Cancer. 2021 Jun;20(2):161-169. doi: 10.1016/j.clcc.2021.02.002. Epub 2021 Feb 19.
10
PD-L1 Expression in Colorectal Adenocarcinoma Is Associated With the Tumor Immune Microenvironment and Epithelial-Mesenchymal Transition.结直肠腺癌中 PD-L1 的表达与肿瘤免疫微环境和上皮-间充质转化相关。
Am J Clin Pathol. 2022 Oct 6;158(4):506-515. doi: 10.1093/ajcp/aqac077.

引用本文的文献

1
SLFN11, far from being limited to responding to cancer DNA damage.SLFN11远不止局限于对癌症DNA损伤作出反应。
Clin Exp Med. 2025 Aug 26;25(1):304. doi: 10.1007/s10238-025-01776-y.
2
From predictive biomarker to therapeutic target: the dual role of SLFN11 in chemotherapy sensitivity.从预测性生物标志物到治疗靶点:SLFN11在化疗敏感性中的双重作用。
Cancer Chemother Pharmacol. 2025 Jun 18;95(1):60. doi: 10.1007/s00280-025-04781-w.

本文引用的文献

1
Mechanistic understanding of human SLFN11.对人类 SLFN11 的机制理解。
Nat Commun. 2022 Sep 17;13(1):5464. doi: 10.1038/s41467-022-33123-0.
2
Schlafen family is a prognostic biomarker and corresponds with immune infiltration in gastric cancer.Schlafen 家族是一个预后生物标志物,与胃癌的免疫浸润相对应。
Front Immunol. 2022 Aug 25;13:922138. doi: 10.3389/fimmu.2022.922138. eCollection 2022.
3
Does Elevated Pre-Treatment Plasma PD-L1 Level Indicate an Increased Tumor Burden and Worse Prognosis in Metastatic Colorectal Cancer?
治疗前血浆PD-L1水平升高是否表明转移性结直肠癌的肿瘤负荷增加及预后更差?
J Clin Med. 2022 Aug 17;11(16):4815. doi: 10.3390/jcm11164815.
4
Pathological Features and Prognostication in Colorectal Cancer.结直肠癌的病理特征与预后
Curr Oncol. 2021 Dec 13;28(6):5356-5383. doi: 10.3390/curroncol28060447.
5
Prognostic impact of Schlafen 11 in bladder cancer patients treated with platinum-based chemotherapy.SLFN11 在接受铂类化疗的膀胱癌患者中的预后影响。
Cancer Sci. 2022 Feb;113(2):784-795. doi: 10.1111/cas.15207. Epub 2021 Dec 7.
6
A wake-up call for cancer DNA damage: the role of Schlafen 11 (SLFN11) across multiple cancers.癌症 DNA 损伤的警钟:SLFN11(Schlafen 11)在多种癌症中的作用。
Br J Cancer. 2021 Nov;125(10):1333-1340. doi: 10.1038/s41416-021-01476-w. Epub 2021 Jul 22.
7
Physical activity and cancer risk. Actual knowledge and possible biological mechanisms.体力活动与癌症风险。实际知识和可能的生物学机制。
Radiol Oncol. 2021 Jan 12;55(1):7-17. doi: 10.2478/raon-2020-0063.
8
Schlafen 11 predicts response to platinum-based chemotherapy in gastric cancers.睡眠 11 预测胃癌对铂类化疗的反应。
Br J Cancer. 2021 Jul;125(1):65-77. doi: 10.1038/s41416-021-01364-3. Epub 2021 Mar 30.
9
Oxidative Stress in the Tumor Microenvironment and Its Relevance to Cancer Immunotherapy.肿瘤微环境中的氧化应激及其与癌症免疫治疗的相关性。
Cancers (Basel). 2021 Feb 27;13(5):986. doi: 10.3390/cancers13050986.
10
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.